 | • レポートコード：MRC2102QY9671 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の神経調節装置・埋め込み型輸液ポンプ市場について種類別（脊髄刺激、脳深部刺激療法、仙骨神経刺激療法、迷走神経刺激療法、胃刺激療法、経頭蓋磁気刺激療法、経皮的電気刺激療法、その他）、用途別（パーキンソン病、てんかん、痛み、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・神経調節装置・埋め込み型輸液ポンプ市場の概要 ・世界の主要地域別神経調節装置・埋め込み型輸液ポンプ市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の神経調節装置・埋め込み型輸液ポンプ市場規模2015-2026：種類別（脊髄刺激、脳深部刺激療法、仙骨神経刺激療法、迷走神経刺激療法、胃刺激療法、経頭蓋磁気刺激療法、経皮的電気刺激療法、その他） ・世界の神経調節装置・埋め込み型輸液ポンプ市場規模2015-2026：用途別（パーキンソン病、てんかん、痛み、その他） ・神経調節装置・埋め込み型輸液ポンプの米国市場規模2015-2020 ・神経調節装置・埋め込み型輸液ポンプのヨーロッパ市場規模2015-2020 ・神経調節装置・埋め込み型輸液ポンプの中国市場規模2015-2020 ・神経調節装置・埋め込み型輸液ポンプの日本市場規模2015-2020 ・神経調節装置・埋め込み型輸液ポンプの東南アジア市場規模2015-2020 ・神経調節装置・埋め込み型輸液ポンプのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・神経調節装置・埋め込み型輸液ポンプの製造コスト分析 ・販売チャネル、流通業者、顧客 ・神経調節装置・埋め込み型輸液ポンプの市場動向・機会・課題 ・調査の結論 |
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
The production mainly distributed in two regions of USA: Puerto Rico (83%), Massachusetts (17%). Medtronic is the manufacturing giants in this field, taking about 83% of the USA production. Medtronic is the largest player with 83% production market, followed by Codman & Shurtleff (J&J) with 15% in 2015.
USA implantable infusion pumps consumption increased from 23.71 K units in 2011 to 28.69 K units in 2015, with an average growth rate of 3.85%. Cancer Treatment and chronic pain treatment are the major fields where implantable infusion pumps are frequently used. In 2015, 18.14 K units’ implantable infusion pumps were used to relieve the pain of Cancer, accounting for 66.6% of the USA total consumption. 26% of implantable infusion pumps were used for chronic pain treatment.
With fast technology development and strong demand, implantable infusion pumps price kept relatively stable and changed from 9964 USD/Unit in 2011 to 9456 USD/Unit in 2015.
It is expected that the USA implantable infusion pumps comsumption will be 35 K Units in 2021 and the production revenue will reach 311 million USD. At the same time, the price may gradually decline. This industry is easily affected by the technological innovation and the policy.
Market Analysis and Insights: Global Neuromodulation Devices and Implantable Infusion Pumps Market
The global Neuromodulation Devices and Implantable Infusion Pumps market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Neuromodulation Devices and Implantable Infusion Pumps Scope and Market Size
The global Neuromodulation Devices and Implantable Infusion Pumps market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuromodulation Devices and Implantable Infusion Pumps market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Neuromodulation Devices and Implantable Infusion Pumps market is segmented into
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segment by Application, the Neuromodulation Devices and Implantable Infusion Pumps market is segmented into
Parkinson’s disease
Epilepsy
Pain
Other
The Neuromodulation Devices and Implantable Infusion Pumps market is analysed and market size information is provided by regions (countries). Segment by Application, the Neuromodulation Devices and Implantable Infusion Pumps market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Neuromodulation Devices and Implantable Infusion Pumps Market Share Analysis
Neuromodulation Devices and Implantable Infusion Pumps market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neuromodulation Devices and Implantable Infusion Pumps business, the date to enter into the Neuromodulation Devices and Implantable Infusion Pumps market, Neuromodulation Devices and Implantable Infusion Pumps product introduction, recent developments, etc.
The major vendors covered:
Medtronic
Boston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
1 Neuromodulation Devices and Implantable Infusion Pumps Market Overview
1.1 Neuromodulation Devices and Implantable Infusion Pumps Product Scope
1.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2020-2026)
1.2.2 Spinal Cord Stimulation
1.2.3 Deep Brain Stimulation
1.2.4 Sacral Nerve Stimulation
1.2.5 Vagal Nerve Stimulation
1.2.6 Gastric Stimulation
1.2.7 Transcranial magnetic Stimulation
1.2.8 Transcutaneous Electrical Stimulation
1.2.9 Other
1.3 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Comparison by Application (2020-2026)
1.3.2 Parkinson’s disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Other
1.4 Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Forecasts (2015-2026)
1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate (2015-2026)
1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2015-2026)
1.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price Trends (2015-2026)
2 Neuromodulation Devices and Implantable Infusion Pumps Estimate and Forecast by Region
2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2015-2020)
2.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2015-2020)
2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Neuromodulation Devices and Implantable Infusion Pumps Estimates and Projections (2015-2026)
2.4.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Estimates and Projections (2015-2026)
2.4.3 China Neuromodulation Devices and Implantable Infusion Pumps Estimates and Projections (2015-2026)
2.4.4 Japan Neuromodulation Devices and Implantable Infusion Pumps Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Estimates and Projections (2015-2026)
2.4.6 India Neuromodulation Devices and Implantable Infusion Pumps Estimates and Projections (2015-2026)
3 Global Neuromodulation Devices and Implantable Infusion Pumps Competition Landscape by Players
3.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Players by Sales (2015-2020)
3.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Players by Revenue (2015-2020)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2019)
3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Company (2015-2020)
3.5 Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Neuromodulation Devices and Implantable Infusion Pumps Players (Opinion Leaders)
4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Review by Type (2015-2020)
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2015-2020)
4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2015-2020)
4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2021-2026)
4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2021-2026)
4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Type (2021-2026)
5 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historic Market Review by Application (2015-2020)
5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2015-2020)
5.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2015-2020)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2021-2026)
5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2021-2026)
5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Application (2021-2026)
6 United States Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures
6.1 United States Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2015-2020)
6.2 United States Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
6.3 United States Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
7 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2015-2020)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
8 China Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures
8.1 China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2015-2020)
8.2 China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
8.3 China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
9 Japan Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures
9.1 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (3015-3030)
9.2 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
9.3 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
10 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures
10.1 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
11 India Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures
11.1 India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2015-2020)
11.2 India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
11.3 India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Neuromodulation Devices and Implantable Infusion Pumps Business
12.1 Medtronic
12.1.1 Medtronic Corporation Information
12.1.2 Medtronic Business Overview
12.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.1.5 Medtronic Recent Development
12.2 Boston Scientific Corporation
12.2.1 Boston Scientific Corporation Corporation Information
12.2.2 Boston Scientific Corporation Business Overview
12.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.2.5 Boston Scientific Corporation Recent Development
12.3 Abbott
12.3.1 Abbott Corporation Information
12.3.2 Abbott Business Overview
12.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Abbott Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.3.5 Abbott Recent Development
12.4 Synapse Biomedical
12.4.1 Synapse Biomedical Corporation Information
12.4.2 Synapse Biomedical Business Overview
12.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.4.5 Synapse Biomedical Recent Development
12.5 Nevro Corporation
12.5.1 Nevro Corporation Corporation Information
12.5.2 Nevro Corporation Business Overview
12.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.5.5 Nevro Corporation Recent Development
12.6 Neuropace
12.6.1 Neuropace Corporation Information
12.6.2 Neuropace Business Overview
12.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.6.5 Neuropace Recent Development
12.7 Cyberonics
12.7.1 Cyberonics Corporation Information
12.7.2 Cyberonics Business Overview
12.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.7.5 Cyberonics Recent Development
12.8 Autonomic Technologies
12.8.1 Autonomic Technologies Corporation Information
12.8.2 Autonomic Technologies Business Overview
12.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.8.5 Autonomic Technologies Recent Development
12.9 Avery Biomedical
12.9.1 Avery Biomedical Corporation Information
12.9.2 Avery Biomedical Business Overview
12.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.9.5 Avery Biomedical Recent Development
12.10 Greatbatch Medical
12.10.1 Greatbatch Medical Corporation Information
12.10.2 Greatbatch Medical Business Overview
12.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Products Offered
12.10.5 Greatbatch Medical Recent Development
13 Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Cost Analysis
13.1 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
13.4 Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors List
14.3 Neuromodulation Devices and Implantable Infusion Pumps Customers
15 Market Dynamics
15.1 Neuromodulation Devices and Implantable Infusion Pumps Market Trends
15.2 Neuromodulation Devices and Implantable Infusion Pumps Opportunities and Drivers
15.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
15.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Neuromodulation Devices and Implantable Infusion Pumps Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Region (2015-2020)
Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2015-2020)
Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Region (2015-2020)
Table 8. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share Forecast by Region (2021-2026)
Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps (K Units) of Key Companies (2015-2020)
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Company (2015-2020)
Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Company (2015-2020)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromodulation Devices and Implantable Infusion Pumps as of 2019)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Sites and Area Served
Table 19. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Neuromodulation Devices and Implantable Infusion Pumps Players
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Type (2015-2020)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Type (2015-2020)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Price (K Units) by Type (2015-2020)
Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Type (2021-2026)
Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2021-2026)
Table 29. Global Neuromodulation Devices and Implantable Infusion Pumps Price (K Units) by Type (2021-2026)
Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Application (2015-2020)
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Application (2015-2020)
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Price (K Units) by Application (2015-2020)
Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Application (2021-2026)
Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Application (2021-2026)
Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Application (2021-2026)
Table 38. Global Neuromodulation Devices and Implantable Infusion Pumps Price (K Units) by Application (2021-2026)
Table 39. United States Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Company (2015-2020)
Table 40. United States Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2015-2020)
Table 41. United States Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Type (2015-2020)
Table 42. United States Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
Table 43. United States Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Application (2015-2020)
Table 44. United States Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
Table 45. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Company (2015-2020)
Table 46. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2015-2020)
Table 47. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Type (2015-2020)
Table 48. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
Table 49. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Application (2015-2020)
Table 50. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
Table 51. China Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Company (2015-2020)
Table 52. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2015-2020)
Table 53. China Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Type (2015-2020)
Table 54. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
Table 55. China Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Application (2015-2020)
Table 56. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
Table 57. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Company (2015-2020)
Table 58. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2015-2020)
Table 59. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Type (2015-2020)
Table 60. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
Table 61. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Application (2015-2020)
Table 62. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
Table 69. India Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Company (2015-2020)
Table 70. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2015-2020)
Table 71. India Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Type (2015-2020)
Table 72. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2015-2020)
Table 73. India Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) by Application (2015-2020)
Table 74. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2015-2020)
Table 75. Medtronic Corporation Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product
Table 79. Medtronic Recent Development
Table 80. Boston Scientific Corporation Corporation Information
Table 81. Boston Scientific Corporation Description and Business Overview
Table 82. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
Table 84. Boston Scientific Corporation Recent Development
Table 85. Abbott Corporation Information
Table 86. Abbott Description and Business Overview
Table 87. Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Abbott Neuromodulation Devices and Implantable Infusion Pumps Product
Table 89. Abbott Recent Development
Table 90. Synapse Biomedical Corporation Information
Table 91. Synapse Biomedical Description and Business Overview
Table 92. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 94. Synapse Biomedical Recent Development
Table 95. Nevro Corporation Corporation Information
Table 96. Nevro Corporation Description and Business Overview
Table 97. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
Table 99. Nevro Corporation Recent Development
Table 100. Neuropace Corporation Information
Table 101. Neuropace Description and Business Overview
Table 102. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product
Table 104. Neuropace Recent Development
Table 105. Cyberonics Corporation Information
Table 106. Cyberonics Description and Business Overview
Table 107. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product
Table 109. Cyberonics Recent Development
Table 110. Autonomic Technologies Corporation Information
Table 111. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Autonomic Technologies Description and Business Overview
Table 113. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product
Table 114. Autonomic Technologies Recent Development
Table 115. Avery Biomedical Corporation Information
Table 116. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Avery Biomedical Description and Business Overview
Table 118. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 119. Avery Biomedical Recent Development
Table 120. Greatbatch Medical Corporation Information
Table 121. Greatbatch Medical Description and Business Overview
Table 122. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 124. Greatbatch Medical Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table 128. Neuromodulation Devices and Implantable Infusion Pumps Customers List
Table 129. Neuromodulation Devices and Implantable Infusion Pumps Market Key Trends
Table 130. Neuromodulation Devices and Implantable Infusion Pumps Key Opportunities and Drivers
Table 131. Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Product Picture
Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application in 2020 & 2026
Figure 6. Parkinson's disease Examples
Figure 7. Epilepsy Examples
Figure 8. Pain Examples
Figure 9. Other Examples
Figure 10. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Neuromodulation Devices and Implantable Infusion Pumps Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Neuromodulation Devices and Implantable Infusion Pumps Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Neuromodulation Devices and Implantable Infusion Pumps Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Neuromodulation Devices and Implantable Infusion Pumps Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue in Neuromodulation Devices and Implantable Infusion Pumps 2015 & 2019
Figure 28. Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2015-2020)
Figure 30. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Application (2015-2020)
Figure 32. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2019
Figure 34. United States Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2019
Figure 35. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2019
Figure 36. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2019
Figure 37. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2019
Figure 38. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2019
Figure 39. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2019
Figure 40. China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2019
Figure 41. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2019
Figure 42. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2019
Figure 43. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2019
Figure 44. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2019
Figure 45. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2019
Figure 46. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2019
Figure 47. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2019
Figure 48. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2019
Figure 49. India Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Neuromodulation Devices and Implantable Infusion Pumps
Figure 52. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
Figure 53. Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
迷走神経刺激（VNS）装置の世界市場レポート2020 Market Analysis and Insights: Global Vagus Nerve Stimulation Devices Market The global Vagus Nerve Stimulation Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Vagus Nerve Stimulation Devices Scope and Market Siz…- 脳深部刺激装置の世界市場レポート2020 Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the tre…
- 脊髄刺激装置の世界市場レポート2020 A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a co…
- 埋め込み型輸液ポンプの世界市場レポート2020 Market Analysis and Insights: Global Implantable Infusion Pumps Market The global Implantable Infusion Pumps market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Implantable Infusion Pumps Scope and Market Size The global Im…
- 埋め込み型神経刺激装置の世界市場レポート2020 Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker. Neurostimulation t…